Indication

schistosomiasis

Aliases

Schistosomiasis

1 clinical trial

1 product

Clinical trial

A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults

Status: Completed, Estimated PCD: 2024-03-19

Product